Evidence map›Paper›PMID 12444172›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2002

Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells.

Andrea Cerutti, Hong Zan, Edmund C Kim, Shefali Shah, Elaine J Schattner, András Schaffer, Paolo Casali

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Chronic Lymphocytic Leukemia.Cold Spring Harbor perspectives in medicine · 2021
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. The regulation of IgA class switching.Nature reviews. Immunology · 2008
    Review
  17. Article
  18. Article
  19. Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Andrea CeruttiDivision of Molecular Immunology, Department of Pathology, Weill Medical College of Cornell University, New York, New York 10021, USA. acerutti@med.cornell.edu
Hong Zan
Edmund C Kim
Shefali Shah
Elaine J Schattner
András Schaffer
Paolo Casali
Cornell University · US

Funding

Immunoglobulin class switch DNA recombinationR01AI045011 · NIAID · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CASALI, PAOLO · 2000 to 2011
$3.8M
IMMUNOLOGY RESEARCH TRAINING PROGRAMT32AI007621 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI CESARMAN, ETHEL · 1999 to 2014
$3.4M
SOMATIC HYPERMUTATION IN HUMAN B CELLSR01AR040908 · NIAMS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CASALI, PAOLO · 1992 to 2005
$1.8M
AGING--ANTIBODY RESPONSE TO BACTERIAL AND VIRAL AGSR01AG013910 · NIA · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CASALI, PAOLO · 1997 to 2001
$687k
Immunoglobulin class switch DNA recombinationR56AI045011 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI CASALI, PAOLO · 2012 to 2012
$523k
ROLE OF CD30: CD153-PATHOGENESIS OF RHEUMATOID ARTHRITISR01AR047872 · NIAMS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CERUTTI, ANDREA · 2001 to 2003
$507k
NIAID NIH HHS AI07621NIAID NIH HHS AI45011NIAID NIH HHS R01 AI045011NIAID NIH HHS R56 AI045011NIAID NIH HHS T32 AI007621NIAMS NIH HHS AR40908NIAMS NIH HHS AR47872NIAMS NIH HHS R01 AR040908NIAMS NIH HHS R01 AR047872NIA NIH HHS AG13910
6 · The paper itself

Abstract

Chronic lymphocytic leukemia (CLL) results from the expansion of malignant CD5(+) B cells that usually express IgD and IgM. These leukemic cells can give rise in vivo to clonally related IgG(+) or IgA(+) elements. The requirements and modalities of this process remain elusive. Here we show that leukemic B cells from 14 of 20 CLLs contain the hallmarks of ongoing Ig class switch DNA recombination (CSR), including extrachromosomal switch circular DNAs and circle transcripts generated by direct S micro -->Sgamma, S micro -->Salpha, and S micro -->Sepsilon as well as sequential Sgamma-->Salpha and Sgamma-->Sepsilon CSR. Similar CLL B cells express transcripts for activation-induced cytidine deaminase, a critical component of the CSR machinery, and contain germline I(H)-C(H) and mature V(H)DJ(H)-C(H) transcripts encoded by multiple Cgamma, Calpha, and Cepsilon genes. Ongoing CSR occurs in only a fraction of the CLL clone, as only small proportions of CD5(+)CD19(+) cells express surface IgG or IgA and lack IgM and IgD. In vivo class-switching CLL B cells down-regulate switch circles and circle transcripts in vitro unless exposed to exogenous CD40 ligand and IL-4. In addition, CLL B cells that do not class switch in vivo activate the CSR machinery and secrete IgG, IgA, or IgE upon in vitro exposure to CD40 ligand and IL-4. These findings indicate that in CLL at least some members of the malignant clone actively differentiate in vivo along a pathway that induces CSR. They also suggest that this process is elicited by external stimuli, including CD40 ligand and IL-4, provided by bystander immune cells.

Indexed as

Immunoglobulin Switch RegionRecombination, GeneticAICDA (Activation-Induced Cytidine Deaminase)Base SequenceB-LymphocytesCD40 LigandCytidine DeaminaseDNA, CircularDNA, NeoplasmDown-RegulationHumansImmunoglobulin AImmunoglobulin GInterleukin-4In Vitro TechniquesLeukemia, Lymphocytic, Chronic, B-CellAICDA (Activation-Induced Cytidine Deaminase)CD40 LigandCytidine DeaminaseDNA, CircularDNA, NeoplasmImmunoglobulin AImmunoglobulin GInterleukin-4Recombinant Proteins

Identifiers

PMID12444172
PMCPMC4625981
OpenAlexW2156287496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.